Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90Yttrium microspheres

Digestive Diseases and Sciences

Volumn 53, Issue 9, 2008, Pages 2556-2563

  Jakobs, T F ^a   Saleem, S ^b   Atassi, B ^b   Reda, E ^b   Lewandowski, R J ^b   Yaghmai, V ^b   Miller, F ^b   Ryu, R K ^b   Ibrahim, S ^b   Sato, K T ^b   Kulik, L M ^b   Mulcahy, M F ^b   Omary, R ^b   Murthy, R ^c   Reiser, M F ^a   Salem, R ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fibrosis; Liver metastases; Palliative treatment; Portal hypertension; Radiation induced liver disease; Radioembolization

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER; LIVER FIBROSIS; LIVER HYPERTROPHY; LIVER METASTASIS; MALE; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; VEIN DIAMETER;

DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICROSPHERES; ORGAN SIZE; RADIATION INJURIES; RADIOTHERAPY; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 50249130786     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0148-z     Document Type: Article

References (51)

1. JS Macdonald 1999 Adjuvant therapy of colon cancer CA Cancer J Clin 49 4 202 219
2. A de Gramont A Figer M Seymour M Homerin A Hmissi J Cassidy 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 16 2938 2947
3. JY Douillard D Cunningham AD Roth M Navarro RD James P Karasek 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 9209 1041 1047
4. C Tournigand T Andre E Achille G Lledo M Flesh D Mery-Mignard 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 2 229 237
5. Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the eastern cooperative oncology group study E3200. J Clin Oncol 25(12):1539-1544
6. C Emmanouilides G Sfakiotaki N Androulakis K Kalbakis C Christophylakis A Kalykaki 2007 Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study BMC Cancer 7 91
7. LA Dawson CJ McGinn D Normolle RK Ten Haken S Walker W Ensminger 2000 Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies J Clin Oncol 18 11 2210 2218
8. AS Kennedy C Nutting D Coldwell J Gaiser C Drachenberg 2004 Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 5 1552 1563
9. TF Jakobs RT Hoffmann G Poepperl A Schmitz J Lutz W Koch 2007 Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres Eur Radiol 17 5 1320 1330
10. AS Kennedy D Coldwell C Nutting R Murthy DE Wertman Jr. SP Loehr 2006 Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2 412 425
11. RJ Lewandowski KG Thurston JE Goin CY Wong VL Gates M Van Buskirk 2005 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging J Vasc Interv Radiol 16 12 1641 1651
12. LX Liu WH Zhang HC Jiang 2003 Current treatment for liver metastases from colorectal cancer World J Gastroenterol 9 2 193 200
13. Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D et al (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25(9):1099-1106
14. G Van Hazel A Blackwell J Anderson D Price P Moroz G Bower 2004 Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2 78 85
15. DM Coldwell AS Kennedy CW Nutting 2007 Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer Int J Radiat Oncol Biol Phys 69 3 800 804
16. P Moroz JE Anderson G Van Hazel BN Gray 2001 Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume J Surg Oncol 78 4 248 252
17. Stubbs RS (2006) Portal hypertension and liver surgery following selective internal radiation therapy with 90Yttrium microspheres. J Clin Oncol 24(9):e15
18. A Kennedy S Nag R Salem R Murthy AJ McEwan C Nutting 2007 Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 1 13 23
19. DM Liu R Salem JT Bui A Courtney O Barakat Z Sergie 2005 Angiographic considerations in patients undergoing liver-directed therapy J Vasc Interv Radiol 16 7 911 935
20. R Salem KG Thurston 2006 Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics J Vasc Interv Radiol 17 9 1425 1439
21. R Salem KG Thurston 2006 Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations J Vasc Interv Radiol 17 8 1251 1278
22. JE Dancey FA Shepherd K Paul KW Sniderman S Houle J Gabrys 2000 Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres J Nucl Med 41 10 1673 1681
23. R Salem KG Thurston BI Carr JE Goin JF Geschwind 2002 Yttrium-90 microspheres: radiation therapy for unresectable liver cancer J Vasc Interv Radiol 13 9 Pt 2 223 229
24. JE Goin R Salem BI Carr JE Dancey MC Soulen JF Geschwind 2005 Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities J Vasc Interv Radiol 16 2 Pt 1 205 213
25. S Ho WY Lau TW Leung M Chan PJ Johnson AK Li 1997 Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur J Nucl Med 24 3 293 298
26. S Ho WY Lau TW Leung M Chan YK Ngar PJ Johnson 1996 Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours Eur J Nucl Med 23 8 947 952
27. RJ Lewandowski KT Sato B Atassi RK Ryu AA, Jr Nemcek L Kulik 2007 Radioembolization with (90)y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 4 571 592
28. JA Barnard GS Marshall WW Neblett G Gray FK Ghishan 1986 Noncirrhotic portal fibrosis after Wilms' tumor therapy Gastroenterology 90 4 1054 1056
29. R Phillips DA Karnofsky LD Hamilton JJ Nickson 1954 Roentgen therapy of hepatic metastases Am J Roentgenol Radium Ther Nucl Med 71 5 826 834
30. JT Wharton L Delclos S Gallager JP Smith 1973 Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique Am J Roentgenol Radium Ther Nucl Med 117 1 73 80
31. B Clement JA Grimaud JP Campion Y Deugnier A Guillouzo 1986 Cell types involved in collagen and fibronectin production in normal and fibrotic human liver Hepatology 6 2 225 234
32. Y Yokoi T Namihisa K Matsuzaki A Miyazaki Y Yamaguchi 1988 Distribution of Ito cells in experimental hepatic fibrosis Liver 8 1 48 52
33. JA Ingold GB Reed HS Kaplan MA Bagshaw 1965 Radiation Hepatitis Am J Roentgenol Radium Ther Nucl Med 93 200 208
34. T Alati M Van Cleeff SC Strom RL Jirtle 1988 Radiation sensitivity of adult human parenchymal hepatocytes Radiat Res 115 1 152 160
35. C Sempoux Y Horsmans A Geubel J Fraikin BE Van Beers JF Gigot 1997 Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event Hepatology 26 1 128 134
36. K Lewin RR Millis 1973 Human radiation hepatitis. A morphologic study with emphasis on the late changes Arch Pathol 96 1 21 26
37. LF Fajardo TV Colby 1980 Pathogenesis of veno-occlusive liver disease after radiation Arch Pathol Lab Med 104 11 584 588
38. LF Fajardo 2005 The pathology of ionizing radiation as defined by morphologic patterns Acta Oncol 44 1 13 22
39. L Lim P Gibbs D Yip JD Shapiro R Dowling D Smith 2005 Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies Intern Med J 35 4 222 227
40. RS Stubbs I O'Brien MM Correia 2006 Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients ANZ J Surg 76 8 696 703
41. CY Wong R Salem S Raman VL Gates HJ Dworkin 2002 Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI Eur J Nucl Med Mol Imaging 29 6 815 820
42. CY Wong R Salem F Qing KT Wong D Barker V Gates 2004 Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET J Nucl Med 45 11 1892 1897
43. CY Wong F Qing M Savin J Campbell VL Gates KM Sherpa 2005 Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging J Vasc Interv Radiol 16 8 1101 1106
44. CY Wong M Savin KM Sherpa F Qing J Campbell VL Gates 2006 Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma Cancer Biother Radiopharm 21 4 305 313
45. LD DeLeve HM Shulman GB McDonald 2002 Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease) Semin Liver Dis 22 1 27 42
46. FL Dulley EJ Kanfer FR Appelbaum D Amos RS Hill CD Buckner 1987 Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation Transplantation 43 6 870 873
47. LD DeLeve N Kaplowitz 1995 Mechanisms of drug-induced liver disease Gastroenterol Clin North Am 24 4 787 810
48. L Rubbia-Brandt V Audard P Sartoretti AD Roth C Brezault M Le Charpentier 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 3 460 466
49. FG Fernandez J Ritter JW Goodwin DC Linehan WG Hawkins SM Strasberg 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 6 845 853
50. JN Vauthey TM Pawlik D Ribero TT Wu D Zorzi PM Hoff 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 13 2065 2072
51. TM Pawlik K Olino AL Gleisner M Torbenson R Schulick MA Choti 2007 Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 7 860 868